Clinical trials / Colorado
Psychedelic and ketamine trials recruiting in Colorado
4 trials registered on ClinicalTrials.gov were recruiting at one or more sites in Colorado on 26 Oct 2026. By substance: Psilocybin 4. By condition: depression 1, cancer and end-of-life distress 2.
From the ClinicalTrials.gov registry (US National Library of Medicine), read through its public API on 26 Oct 2026: studies marked as recruiting whose interventions name the substance. Titles, sponsors, phases, conditions and sites are the registry's own entries, written by the sponsors. We have not vetted any trial, and recruiting status changes; the registry record and the study team have the current eligibility rules.
Phase 1PsilocybinNCT07516405
Safety and Tolerability Trial of Psilocybin in Healthy Older Adults (Psil-Pk)
- Conditions:
- Healthy Volunteer; Older Adults (65-85 Years)
- Sponsor:
- University of Colorado, Denver
- Who:
- ages 65 Years to 85 Years, 40 participants planned, accepts healthy volunteers
- University of Colorado Anschutz Medical Campus, Aurora, Colorado
Phase 2/3PsilocybinNCT05398484
Psilocybin Therapy in Advanced Cancer
- Conditions:
- Advanced Cancer
- Sponsor:
- NYU Langone Health
- Who:
- ages 21 Years to 100 Years, 200 participants planned
- University of Colorado Anschutz Medical campus (CU AMC), Aurora, Colorado
Phase 1PsilocybinNCT06430541
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
- Conditions:
- Breast Cancer; Ovarian Cancer
- Sponsor:
- University of Colorado, Denver
- Who:
- ages 21 Years and over, 20 participants planned
- Outpatient CTRC, Aurora, Colorado
- University of Colorado Cancer Center, Aurora, Colorado
Phase 2PsilocybinNCT06512194
Investigation to Understand and Optimize Psilocybin (OPTIMIZE)
- Conditions:
- Depression
- Sponsor:
- Charles Raison
- Who:
- ages 18 Years to 70 Years, 141 participants planned
- Vail Health Behavioral Health, Edwards, Colorado